Spots Global Cancer Trial Database for Intestinal Microflora in Lung Cancer After Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Intestinal Microflora in Lung Cancer After Chemotherapy
Official Title: Intestinal Microflora in Lung Cancer After Chemotherapy
Study ID: NCT02771470
Study Description
Brief Summary: Probiotics modulate the gut microflora and immune status in lung cancer who need chemotherapy.
Detailed Description: Chemotherapy destroys the intestinal mucosal barrier, affects intestinal flora, causing bacterial translocation, infection and other complications. Probiotics may restore the intestinal immunity, mucosal barrier and nutrient absorption.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan, Shandong, China
Contact Details
Name: Yanqing Li, MD.PhD.
Affiliation: Qilu Hospital, Shandong University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
